In this regard, we found that patients with GH lower than 6 ng/ml at diagnosis had a milder acromegaly phenotype, not just biochemically but also regarding tumor burden (smaller and less extrasellar tumor), and more patients achieve disease control with SRL (27). Here, GH1 is linked to acromegaly.